The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Apr. 21, 2014
Applicants:

Kunming Institute of Botany, the Chinese Academy of Sciences, Kunming, Yunnan, CN;

The Key Laboratory of Chemistry for Natural Product of Guizhou Province & Chinese Academy of Science, Guiyang, Guizhou, CN;

Shanghai Institutes for Biological Sciences, Cas, Shanghai, CN;

Institute of Zoology, Chinese Academy of Sciences, Beijing, CN;

Inventors:

Xiaojiang Hao, Yunnan, CN;

Chen Yan, Guizhou, CN;

Haiyang Liu, Yunnan, CN;

Lin Li, Shanghai, CN;

Xiaoli He, Shanghai, CN;

Quan Chen, Beijing, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07C 69/16 (2006.01); C07C 69/18 (2006.01); C07C 69/26 (2006.01); C07C 69/30 (2006.01); C07C 69/63 (2006.01); C07C 69/78 (2006.01); C07C 49/743 (2006.01); C07C 62/38 (2006.01); C07C 205/57 (2006.01); C07D 295/116 (2006.01); C07D 295/185 (2006.01); C07D 333/40 (2006.01); C07D 311/78 (2006.01); A61K 31/366 (2006.01); C07D 311/94 (2006.01); C07D 407/12 (2006.01); C07D 221/28 (2006.01); C07D 327/10 (2006.01); C07D 409/12 (2006.01); C07D 493/08 (2006.01); C07D 493/10 (2006.01); C07D 495/04 (2006.01); C07D 498/08 (2006.01); C07C 309/66 (2006.01); C07C 49/753 (2006.01);
U.S. Cl.
CPC ...
C07D 311/78 (2013.01); A61K 31/366 (2013.01); C07C 49/743 (2013.01); C07C 49/753 (2013.01); C07C 62/38 (2013.01); C07C 69/16 (2013.01); C07C 69/18 (2013.01); C07C 69/26 (2013.01); C07C 69/30 (2013.01); C07C 69/63 (2013.01); C07C 69/78 (2013.01); C07C 205/57 (2013.01); C07C 309/66 (2013.01); C07D 221/28 (2013.01); C07D 295/116 (2013.01); C07D 295/185 (2013.01); C07D 311/94 (2013.01); C07D 327/10 (2013.01); C07D 333/40 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 493/08 (2013.01); C07D 493/10 (2013.01); C07D 495/04 (2013.01); C07D 498/08 (2013.01); C07C 2603/86 (2017.05);
Abstract

The invention relates to a derivative of 15-oxospiramilacton, particularly to a compound of Formula I or II, or an isomer, a solvate or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition comprising the compound as pharmaceutically active ingredient, a method for preparing the same, and use thereof in manufacture of an anti-tumor agent. The derivative of 15-oxospiramilactone of the invention have an activity against multiple tumor cell lines, and the anti-tumor activity is positively correlated to an activity inhibiting the Wnt signaling pathway.


Find Patent Forward Citations

Loading…